Congress-Boston
Congress-Boston

Primary Hyperoxaluria Type 1 (PH1)

American Transplant Congress (ATC) 2026

Congress Details

calanderJune 20-24, 2026

locationBoston, MA

The material below is provided to support scientific exchange and pertains to select congress resources. Any content about investigational therapeutics or investigational uses of locally approved products does not establish the safety or efficacy of these therapeutics or uses, and there is no guarantee of local regulatory approval.

All congress materials are copyrighted by Alnylam. Permission is required to copy or distribute.

For questions beyond a product’s authorized indications or for information not available here, please contact Alnylam Medical Information.

Image
Oral

Agenda

22 June, 2026

Coming soon
Image
icon Presentation Type
Poster
Image
time icon Time
2:45 PM - 3:45 PM ET
Image
location icon Location
Exhibit Hall
Image
icon Title
Lumasiran Treatment and Isolated Kidney Transplantation in Primary Hyperoxaluria 1 and Late-Stage Chronic Kidney Disease
mic Presenter

Teresa Kauf

Alnylam Pharmaceuticals

MA, USA